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Abstract
Background: Alternative splicing has been demonstrated to affect most of human genes; different
isoforms from the same gene encode for proteins which differ for a limited number of residues,
thus yielding similar structures. This suggests possible correlations between alternative splicing and
protein structure. In order to support the investigation of such relationships, we have developed
the Alternative Splicing and Protein Structure Scrutinizer (PASS), a Web application to
automatically extract, integrate and analyze human alternative splicing and protein structure data
sparsely available in the Alternative Splicing Database, Ensembl databank and Protein Data Bank.
Primary data from these databases have been integrated and analyzed using the Protein Identifier
Cross-Reference, BLAST, CLUSTALW and FeatureMap3D software tools.
Results: A database has been developed to store the considered primary data and the results
from their analysis; a system of Perl scripts has been implemented to automatically create and
update the database and analyze the integrated data; a Web interface has been implemented to
make the analyses easily accessible; a database has been created to manage user accesses to the
PASS Web application and store user’s data and searches.
Conclusion: PASS automatically integrates data from the Alternative Splicing Database with
protein structure data from the Protein Data Bank. Additionally, it comprehensively analyzes the
integrated data with publicly available well-known bioinformatics tools in order to generate
structural information of isoform pairs. Further analysis of such valuable information might reveal
interesting relationships between alternative splicing and protein structure differences, which may
be significantly associated with different functions.
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Most of the genes in higher eukaryotes contain introns.
The presence of many introns in higher eukaryotic genes
allows the expression of different proteins (isoforms) in
different tissues from a single gene, phenomenon known
as alternative splicing. In lower eukaryotes, however,
alternative splicing is very rare [1].
It has been estimated that at least 60% of human genes
produces alternatively spliced forms [2], but only for a
small part of the human genes the alternative splicing
variants have been detected, because the regulatory
processes which lead to alternative splicing have not been
well understood yet. Alternative splicing may be important
in understanding cancer, since some cancer-associated
genes have alternatively spliced forms which differ from
the forms in normal tissues. Generally, aberrant splicing
events are responsible for pathologies [3].
Alternative splicing is important also from an evolu-
tionary point of view: different transcripts may be
translated in different departments of the cell, in
different tissues and at different developmental stages,
giving rise to cell, tissue and developmental diversity and
specificity; alternative splicing also allows evolution of
the gene structure [4]. It has been demonstrated that the
alternative first exon plays an important role in protein
diversity at cell and tissue level [5,6].
In a typical alternatively spliced gene most of the exons are
constitutive; hence they are always included in the final
mRNA transcript. The alternative part is composed by:
- skipped exons (cassette exons and mutually exclusive
exons): an entire exon appears in some transcripts but
not in others;
- exon/intron isoforms: the borders of the exon/intron
are different, leading to truncation/extension of introns/
exons;
- intron retentions: an intron is not spliced out (Figure 1).
In addition to these, alternative promoters or alternative
poly-A tails exist: in this case the coding sequence is the
same for all the isoforms, but the untranslated regions
may vary, e.g. alternative promoters that involve
different transcriptional controls.
There are often functional differences among spliced
forms: insertion, deletion or substitution of protein
domains by alternative splicing frequently modifies
protein function by inserting or deleting functional
residues or by substituting the sequence that includes a
functional site. Alternative splicing inserts or deletes
whole protein domains; it does not occur within protein
domains. This can be explained by the fact that exons
may reflect domain boundaries, or that natural selection
may eliminate meaningless alternative splicing variants
which do not result from full domains [7].
To investigate how alternative splicing affects the protein
function, it is important to understand whether the
protein structure is influenced by the insertion/deletion/
substitution of residues. The secondary structure of a
protein is determined when special rearrangements
result from the folding of localized parts of a protein.
Many types of different secondary structures may be
present inside the same protein, due to different non-
covalent interactions between the residues, e.g. hydrogen
bonds produce to alpha helix and beta sheet secondary
structures. Averagely, inside a protein 60% of the chain is
alpha helix or beta sheet, the other 40% is loop. To date,
many different alphabets to define the secondary
Figure 1
Events of alternative splicing.I nat y p i c a la l t e r n a t i v e l y
spliced gene, where most of the exons are constitutive (i.e.
they are always included in the final mRNA), four different
types of alternative splicing events may occur to give rise to
different final transcripts: a) cassette exons (one exon is
skipped in some transcripts), b) isoforms of introns or exons
(their boundaries may be different in different transcripts,
with consequent truncation/extension of the flanking
introns/exons), c) intron retentions (one intron is not spliced
out and may be inserted into the final transcript), d) mutually
exclusive exons (different exons may be included in different
final transcripts). On the right of the figure the alternative
mRNA transcripts are displayed; conserved parts are
colored in green, while alternative elements are colored in
red or blue.
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Definition of Secondary Structure of Proteins (DSSP) [8],
which includes 8 types of structures: H (alpha helix), B
(isolated beta-bridge), E (extended strand, participating
in beta ladder), G (3-helix, i.e. 3/10 helix), I (5-helix, i.e.
pi helix), T (hydrogen bonded turn), S (bend), and
(other).
When analyzing the protein structure, two additional
properties are worth to be investigated: accessibility and
flexibility. The former is a measure of the static solvent
exposure, i.e. the number of water molecules which are
in contact with every residue of the protein: the average
accessibility of the protein is calculated as the average
value over all the residues. The latter, which refers to the
vibration of an atom around its rest position, is
measured as thermal motion of the alpha carbon of
every residue [8].
To automatically extract, integrate, and analyze the
alternative splicing and protein structure data sparsely
available in different distributed databanks, we created a
Web application called Alternative Splicing and Protein
Structure Scrutinizer (PASS). In order to build the PASS
Web application, we: 1) defined a database schema
suitable to store and integrate alternative splicing and
protein structure information extracted from the Alter-
native Splicing Database (ASD) [9], the Ensembl
databank http://www.ensembl.org/[10], and the Protein
Data Bank (PDB, http://www.rcsb.org/) [11]; 2) devel-
oped a software capable of creating and updating the
database by automatically retrieving and integrating data
from different databanks accessible through the Internet;
3) created a software to analyze the retrieved data and
store the results from the analysis inside the database,
a n d4 )d e s i g n e da n di m p l e m e n t e daW e bi n t e r f a c et h a t
allows users to query the database in order to examine
the integrated data and use them to evaluate their own
gene or protein sets.
Results and discussion
PASS database and designed analysis steps
The relational PASS database has been specifically
designed and built by using MySQL DBMS in order to
integrate and store the alternative splicing and protein
structure primary data gathered from three publicly
available databanks (ASD, Ensembl and PDB), as well as
the results of their analysis. It includes data about: 1) the
alternatively spliced protein sequences (e.g. Ensembl
identifier for the codifying gene, splicing pattern, and
peptide sequence); 2) the alternative splicing events
(e.g. type of alternative splicing, splicing patterns among
which it takes place, and the introns/exons on which the
alternative splicing occurs); 3) the reference protein
sequences defined by Ensembl (e.g. Ensembl identifier
for the protein and the codifying gene, cytogenetic
location, and peptide sequence); 4) the protein struc-
tures (e.g. identifiers and sequences from PDB). All these
data are imported and respectively stored in the
AltSplicedProteinSequences, AlternativeSplicingEvents, Refer-
enceProteinSequences,a n dPDB_ProteinSequences tables of
the PASS database (Figure 2).
To obtain information about the possible relationship
between alternative splicing and protein structure, a
multi-step analysis procedure of the integrated data has
been designed. The first step concerns the filtering of all
the reference protein sequences in Ensembl in order to
consider only those proteins which have a resolved
structure in PDB; this allows performing all the
subsequent analyses on a smaller subset of proteins,
thus limiting the computational load required, in
particular, by some time-consuming operations. The
filtering is achieved by using the Protein Identifier Cross-
Reference (PICR, http://www.ebi.ac.uk/Tools/picr/) Web
service, which provides a mapping between Ensembl and
PDB identifiers [12]. PICR maps 3,480 Ensembl human
genes, which correspond to 15.1% of the total human
genes in Ensembl, to 1,942 distinct PDB structures, with
a total of 13,972 associations (4 structures average for
each gene, as more than one protein structure in PDB can
be associated to the same alternative splicing gene).
Mapping results are stored in the PDB_ENSP table of the
PASS database (Figure 2).
A further filtering step is made by performing BLAST [13]
alignments against PDB of each isoform sequence
selected through PICR, in order to assess the associations
between ASD isoforms and PDB structures suggested by
the correspondences between Ensembl reference
sequences and PDB structures obtained from PICR.
This BLAST search selects 3,056 best alignments between
isoforms from ASD and PDB structures (9.5% of the
isoforms in ASD), which correspond to 953 genes (9.6%
of the genes in ASD, and 4.1% of the human genes in
Ensembl). BLAST results are stored in the BLAST_Homol-
ogy table of the PASS database (Figure 2).
Once all proteins with a resolved structure are selected,
CLUSTALW [14] is executed on each couple of isoforms
for which an alternative splicing event is defined in ASD
(i.e. imported and stored in the AlternativeSplicingEvents
table of the PASS database). This allows annotating each
residue of the two isoforms according to the alignment
between their alternatively spliced sequences: hence it is
possible to verify whether a residue is conserved between
the two spliced forms, and whether there are mismatches
or gaps. Through CLUSTALW the annotation for both
aligned sequences and the position of the alternative
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tions for the alternative elements were defined and
stored in the Annotation table of the PASS database
(Figure 2): 0 (inner alternative element), 1 (more than
one alternative element), 2 (terminal alternative ele-
ment), 3 (only mismatches between the two sequences
are present), 4 (element aligned to a gap: this happens if
the two sequences do not overlap), 5 (element shared
between the two sequences), 6 (either mismatches or
insertions are defined). The data derived from the
analysis with CLUSTALW are stored in the ClustalwA-
lignedSequences table of the PASS database (Figure 2). In
ASD 52,248 events of alternative splicing are described
for 23,295 isoforms (72.6% of the isoforms defined in
ASD) and 6,384 genes (64.2% of the genes in ASD). By
combining the alternative splicing event data with the
results from the previous step of BLAST filtering and the
residue annotation through CLUSTALW, 3,951 alterna-
tive splicing events are annotated (7.6% of the events in
ASD), which regard 599 genes and 2,149 isoforms (6%
of the genes with alternative splicing, and 6.7% of the
total isoforms in ASD).
The last step was designed in order to determine in
which type of protein secondary structure each anno-
tated residue of alternatively spiced isoforms is involved.
Data from the previous annotation step are processed
using FeatureMap3D [15], which uses BLAST to align a
Figure 2
Entities-Relationships diagram of the PASS database. The PASS database is composed of several parts:
ReferenceProteinSequences, AltSplicedProteinSequences, AlternativeSplicingEvents and PDB_ProteinSequences contain the primary
data from ASD, Ensembl and PDB; PDB_ENSP, BLAST_Homology and ClustalwAlignedSequences contain the analysis data from
PICR, BLAST and CLUSTALW, respectively; Annotation contains the different possible positions defined for the alternative
elements of a couple of protein sequences (and used in the residue annotation); while FeatureMap3D_Reports, AverageStructures
and Residues contain the FeatureMap3D analysis results and their processing.
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structure of the input sequence. BLAST results from
FeatureMap3D are stored in the FeatureMap3D_Reports
table of the PASS database (Figure 2). FeatureMap3D
also provides a detailed report about the protein
secondary structure in which every single residue in the
query sequence, which is aligned against its best match
sequence in PDB, is involved. Data from these reports are
stored in the Residues and AverageStructures tables of the
PASS database (Figure 2). The former table includes all
the structural data, residue by residue (position on the
sequence, coordinates, secondary structure, annotation
from CLUSTALW, accessibility and flexibility), while the
latter includes the average structural distribution, both
for the whole protein and divided by type of annotation.
Thus, these data define whether a particular structural
pattern is present for a particular type of alternative
splicing event. By processing the sequences from the
annotations generated by CLUSTALW, FeatureMap3D
defines 5,604 structures to which 768,477 residues of
1,569 isoforms coming from 480 genes (4.8% of the
genes with alternative splicing) belong. Table 1 shows a
c o m p r e h e n s i v ev i e wo ft h ea m o u n to fd a t as t o r e di nt h e
PASS database.
Software system to create and update the database
automatically
All steps of the procedure previously described are
executed automatically through a system of Perl scripts
specifically implemented. The first step consists in the
download, with consequent extraction and import into
the PASS database, of the primary data from ASD,
Ensembl and PDB databanks. After populating the
corresponding tables inside the database, the following
steps are performed by automatically executing the PICR,
BLAST and CLUSTALW software and storing the results
of each step in the PASS database. The results from
CLUSTALW are also saved into a text file required as
input to FeatureMap3D software, which is executed
online http://www.cbs.dtu.dk/services/FeatureMap3D/
to complete the last step of the analysis. Results from
FeatureMap3D are stored in 4 distinct files for each
considered protein sequence: the PDB file of the protein
structure, a PyMOL script (generated automatically by
FeatureMap3D) to color the structure according to the
considered sequence annotation (Figure 3), a PNG
image of the structure, and a report file with the
description of the protein secondary structure residue
by residue. This file is parsed and its content is stored
into the Residues and AverageStructures tables in the PASS
database.
PassUsers database
In order to manage users’ registrations to the PASS Web
application and users’ input and PASS database search
data, the relational PassUsers database has been devel-
oped by using MySQL DBMS. It allows: 1) maintaining
the information about PASS registered users and
recognize them when they log in; 2) storing all the
data the registered users upload in the PASS system; 3)
storing all the queries to search and extract data in the
PASS database that the registered users manually define
and want to save in order to be performed at later time
without needing to redefine them.
The PassUser database is composed of several tables. The
Users table contains the data requested for the PASS user
registration (Figure 4). The registered user may upload
his or her own set of data in the PASS system, where they
are stored in two tables: DataSets, which includes the
information of the user’s uploaded datasets, and
UploadedData, which contains all the uploaded data.
The DataTypes table defines whether the data uploaded
by the user are composed of ENSP identifiers, ENSG
Table 1: Summary of the data integrated and stored in the PASS database
Source and type of data Total % of total in Ensembl % of total in ASD
Ensembl genes 22,997 100.00 -
isoforms 46,951 100.00 -
ASD genes 9,945 43.24 100.00
isoforms 32,079 68.32 100.00
alternative splicing events 52,248 - -
PDB structures 111,015 - -
Ensembl genes with a resolved structure (from PICR) 3,480 15.13 -
Mapping from BLAST against PDB genes 953 4.14 9.58
isoforms 3,056 6.51 9.53
Alignments produced by CLUSTALW genes 599 2.60 6.02
isoforms 2,149 4.58 6.70
Results from FeatureMap3D genes 480 2.09 4.83
isoforms 1,569 3.34 4.89
residues 768,477 - -
structures 5,604 - -
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(e.g. “cassette exons”).
The Queries table contains all the predefined SQL queries
the user can use to interrogate the PASS database. Each
record of the table contains information about the
FROM and WHERE clauses of the SQL queries, while the
SELECT clauses of the queries are visually composed by
the user and stored in the Fields table associated to the
user performed database searches stored in the Searches
table. In this way, the user can choose the query to
perform, as well as the result fields to display in the Web
interface, and can save them to be used at later time to
perform the desired searches in the PASS database.
Web interface
By using Javascript and Active Server Pages scripts, a Web
interface has been implemented to enable PASS users to
easily extract and further analyze all the data stored in
the PASS database, and use them to evaluate their own
gene or protein datasets. Two types of users have been
defined: basic and privileged, which can also save their
searches and access them at later time. Privileged status is
granted by PASS administrators upon evaluation of user
request. After registering to PASS, users can upload their
Ensembl gene or protein identifiers, or splicing event
types, as defined in the ASD database, and perform
several kinds of searches, including some that allow
alternative splicing and structural data analysis of their
uploaded genes and proteins. In the search main Web
page (Figure 5) the user can define a name for the search
to perform (so that it can be saved and performed again
at later time) and select the user’s uploaded dataset (of
gene, protein or splicing event identifiers) to use for
searching information in the PASS database, and the
query to apply. In the subsequent Web page, the user can
also define what specific data field (among all those
extractable with the chosen query) to display, and in
which format (table or bar plot) to display or download
the results.
Several queries have been implemented for the PASS
users. The simplest of them allows the user to extract in
tabular format information about alternatively spliced
protein sequences, alternative splicing events, proteins
with a resolved structure, or protein annotations from
CLUSTALW. A second set of queries, which regards the
data from the structural analysis, allows performing
different investigations based on the results from
FeatureMap3D. First, a user can gather information
about the average secondary structure of the alternatively
spliced protein sequences referenced in a dataset; in this
case, the user may choose to display query results: 1) in a
s i m p l et a b l ew i t hac o l u m nf o re a c hd a t af i e l d ,o r2 )a s
bar plots of the secondary structure distributions,
together with bar plots of accessibility and flexibility
values for the considered proteins (Figure 6), in order to
visually detect different patterns of secondary structure
distribution for the different isoforms. Then, similarly,
the user may extract the secondary structure distribution
for the different types of annotation (by type of
alternative splicing event, or by alternative element
position), in order to detect whether insertions/dele-
tions/mismatches bring variations in the protein struc-
ture. These analyses may be of fundamental support for
several investigations:
- to determine whether a particular type of insertion has
a preferred structural pattern;
-i np r e s e n c eo fa ni n n e ra l t e r n a t i v ee x o n ,t oe v a l u a t e
whether the inserted element might be more rigid or
more flexible than the rest of the protein;
- in presence of mismatches, to determine whether the
substituted residues are on the protein’ss u r f a c e( a s
indicated by high accessibility values); furthermore, if
Figure 3
Protein structures colored according to their residue
annotation. Example of the isoforms for the gene
ENSG00000104870 (IgG receptor FcRn large subunit p51
precursor): the same isoform (a, c) is aligned using
CLUSTALW to two other different isoforms (b, d) of the
same gene. The parts conserved between the two aligned
isoforms are colored in green, the residues conserved only in
one isoform are colored in blue (the first and last residue of
the insertion are colored in red in the other isoform), and
the different mismatches between the two sequences are
depicted in other colors, based on whether the substitution
has a positive or negative value in the BLOSUM62 matrix.
The images are obtained with PyMOL http://www.pymol.org/
.
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Entities-Relationships diagram of the PassUsers database. The PassUsers database is composed of three main parts
that store: the registration data for every user (Users), the data uploaded by the user (DataSets, with the definition of the
uploaded datasets; DataTypes, with the definition of the type of data uploaded; and UploadedData, with all the identifiers
uploaded for every dataset), and the user's search data (Searches, with the searches defined by every user; Queries,w i t ha l lt h e
queries the user may make; and Fields, with the information about what field in the SELECT statement of the query the user has
chosen to display).
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splicing pattern (as indicated by their low values in the
BLOSUM62 matrix [16]), then the overall properties of
the isoforms, such as polarity and solubility, might differ
significantly.
A last set of implemented queries allows the PASS user to
export the processed data stored in the PASS database by
downloading query results as flat files, which may be
inputted to other programs such as Excel, MatLAB or R,
in order to further analyze them. Towards this aim,
several possibilities have been implemented: 1) extract
the average structure and the accessibility and flexibility
values for all the alternatively spliced genes; 2) extract
the average structures sorted by annotation, in order to
determine whether conserved residues have a different
structural pattern than the alternatively spliced ones;
3) extract the average structures sorted by position of the
alternative element, in order to understand whether a
particular type of insertion may affect the protein
Figure 5
Search section of the PASS Web application. Screenshot of the PASS search main page that enables users to define the
initial parameters of a search to be performed in the PASS database.
Figure 6
Example of structural analysis. Isoforms (identified by the ENSP code of the reference protein and their splicing pattern)
of the gene ENSG00000170899 (Glutathione S-transferase A4) and bar plot composition of their structure: alpha helices
(green), extended strands participating in beta ladder (blue), 3-helices (yellow), hydrogen bonded turns (purple), bends
(white), and other structures (cyan); the last two columns on the right contain the bar plots of the accessibility (static solvent
exposure) and flexibility (B factor) values of the isoforms.
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the type of alternative splicing event, in order to
understand whether the event type may affect the protein
structure.
Conclusion
The Alternative Splicing and Protein Structure Scrutinizer
(PASS) has been developed as a Web application able to
make large scale automatic analyses of alternative
splicing and protein structures of human genes. PASS
can provide numerous results: from the simple analyses
of protein sequences (either structural or about alter-
native splicing), to the extraction of protein structural
information, which is the basis for determining the
relationship between alternative splicing and protein
structure. All data processing and analyses are performed
automatically; this allows executing large scale analyses:
more than one thousand protein structures have been
investigated and results are available in the PASS
database. By using them the PASS Web application is
able to process all the human genes and proteins
required by the user and provide information about
t h ea n a l y s i so ft h e i rs t r u c t u r e .T h er e s u l t sm a yb ee i t h e r
visual (in form of bar plots that enable the user to
immediately perceive the differences in protein second-
ary structure distribution among the considered
sequences), or in form of tables that may be downloaded
for further investigations with specific software tools. To
our knowledge, at present there is no other software or
databank available that can provide similar integrated
information. Evaluation of such valuable information
stored in the PASS database might reveal interesting
correlations between alternative splicing and protein




As source of information we considered the following
three databanks:
- The Alternative Splicing Database (ASD) from the
European Bioinformatics Institute (EBI) http://www.ebi.
ac.uk/asd/[9] was used as source for human alternative
splicing data. This is a computer generated high quality
databank which includes data from gene/transcript
sequence (EST/mRNA) alignments. These data are
cleaned from ambiguities and analyzed: alignment
gaps are potential introns while matches in the align-
ment correspond to exons if they are flanked on both
sides by introns. Introns and exons which overlap with
one another correspond to alternative splicing events;
these events are described as skipped exons, exon/intron
isoforms, or alternative exon events. The alternative
splicing events are defined between different isoforms
from a single gene: each of them contains the type of
alternative splicing, the splicing patterns between which
the event occurs, and the introns/exons which are
involved in the alternative splicing event. The latest
version (release 3) of the alternatively spliced protein
sequences (AltSplice-rel3.peptides.fasta) and the definition
of the alternative splicing events (AltSplice-rel3.events.txt)
have been downloaded from the ASD FTP site at EBI
ftp://ftp.ebi.ac.uk/pub/databases/astd/altsplice/human/
latest/. The ASD includes analyses on 9,945 genes and
32,079 isoforms, among which 52,248 events of alter-
native splicing are defined (Figure 7a).
- The Ensembl databank http://www.ensembl.org/ [10]
was used as reference benchmark for the human genes.
T h er e l e a s e4 8o ft h el i s to fh u m a nr e f e r e n c ep r o t e i n
sequences, which includes 22,997 human genes, was
downloaded from the Ensembl FTP site ftp://ftp.
ensembl.org/pub/current_fasta/homo_sapiens/pep/.
Each considered entry contains the Ensembl gene and
protein identifiers, the position of the gene on the
chromosome, and the protein sequence.
- The Protein Data Bank (PDB) [11] release of February
10
th 2008 with protein sequences in FASTA format
(pdb_seqres.txt) has been downloaded from ftp://ftp.
wwpdb.org/pub/pdb/derived_data/; 111,015 protein
structures are included in this release.
Bioinformatics software and tools
Within the PASS Web application the bioinformatics
tools following described are used:
- The Protein Identifier Cross-Reference (PICR) http://
www.ebi.ac.uk/Tools/picr/ [12] has been developed by
EBI to map identifiers and sequences between different
databanks. We used its Web service version to map all
the Ensembl protein identifiers (ENSP) to the PDB
identifiers, in order to avoid doing a BLAST of all
Ensembl against all PDB.
- BLASTALL, which has been downloaded as stand alone
executable program from http://www.ebi.ac.uk/blastall/,
is used to blast alternatively spliced protein sequences
against PDB; it has been chosen because it allows
defining the database of hit sequences to be used. To
this aim, two steps need to be undertaken: 1) define the
database of hit sequences: this is done by running the
command “FORMATDB”, and 2) run the command
“BLASTALL -p BLASTP -m 8”, where the parameter
“-p BLASTP” defines that the BLAST is made for amino
acid residues and the parameter “-m 8” defines that the
output must be in tabular format [13]. By taking
BMC Bioinformatics 2009, 10(Suppl 12):S15 http://www.biomedcentral.com/1471-2105/10/S12/S15
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Examples of the primary data considered. a) Example data of the alternative splicing events of gene ENSG00000104870
extracted from the ASD database. b) Output alignment from CLUSTALW of two alternatively spliced proteins from the gene
in a); * indicates a conserved residue. c) Residue annotation defined for the pair of CLUSTALW aligned sequences in b); the
residues labeled as “1” are present only in one sequence, the residues labeled as “2” represent the positions where residues
are inserted in the other sequence, and the residues labeled as “.” are conserved in the two sequences. d) Output report of the
FeatureMap3D analysis of the annotated sequences displayed in c); the data colored in red are those extracted and stored into
the PASS database.
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spliced protein sequences from the genes which have a
significant hit in PDB are aligned against the protein
sequences which have a defined three dimensional
structure in PDB. Proceeding this way, the computa-
tional load is significantly reduced in comparison with
an all-against-all BLAST search.
- CLUSTALW [14], downloaded as stand alone execu-
table program from http://www.ebi.ac.uk/Tools/clus-
talw2/[14], is used to annotate every residue in each
considered couple of alternatively spliced sequences
between which an alternative splicing event is defined
(Figure 7b). The output from CLUSTALW (an ALN file)
defines the annotation as follows: (residue shared
between the two spliced forms); 1 (residue present
only in the analyzed splicing pattern); 2 (start and finish
position of a gap for the analyzed isoform); 3 (mismatch
between the two spliced forms, with substitution
between two residues which are very alike; i.e. when
the value between the two mismatched residues in the
BLOSUM62 matrix [16] is > 0); 4 (mismatch between the
two spliced forms, with substitution between two
residues which have a value = 0 between them in the
BLOSUM62 matrix); 5 (mismatch between the two
spliced forms, with substitution between two residues
which have opposite properties, e.g. a positively charged
and a non-polar residue; i.e. when the value between the
twomismatchedresiduesintheBLOSUM62matrixis<0)
(Figure 7c). It is relevant to understand whether a
mismatch is between similar residues (a high value in
the BLOSUM62 matrix) because the properties of similar
residues, such as polarity or dimensions, are alike; thus a
substitution between such residues would not affect the
whole protein structure.
- FeatureMap3D http://www.cbs.dtu.dk/services/Feature-
Map3D/[15] is a Web tool which permits to blast a
protein sequence against PDB in order to search for the
protein structure in PDB (BLASTP is used to align the
query sequence against PDB). If an annotation is added
to the blasted sequence (by submitting a TAB file instead
of a FASTA file), FeatureMap3D differently colors the
differently annotated parts of the retrieved structure;
otherwise it uses the alignment of the query sequence
a g a i n s tt h eP D Bs t r u c t u r ea sa n n o t a t i o nf o rt h ed i f f e r e n t
colors and generates a PyMOL script and an annotated
pairwise alignment. From FeatureMap3D different types
of outputs may be downloaded: the PDB file of the
identified structure; the PyMOL script to color the
s t r u c t u r ea sd e f i n e db yt h ea n n o t a t i o n ;t h eP N Gi m a g e
of the structure; the FeatureMap3D report, which is
divided in two parts: first, a summary of the information
about the protein (protein name, user’sd e f i n e dn a m e ,
PDB identifier, structure’s resolution, and a report of the
BLAST between the query protein sequence and PDB),
and second, a table of the protein structural properties,
residue by residue (Figure 7d). The report file is used to
extract all the structural information imported and
stored into the PASS database.
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